Levi & Korsinsky, LLP reminds shareholders that a BSX class action lawsuit has been commenced on behalf of investors who purchased Boston Scientific Corporation (BSX) securities between April 24, 2019 and November 16, 2020. For more on the Boston Scientific Class Action please contact us today.

According to the Boston Scientific lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the LOTUS Edge Aortic Valve System’s product delivery system was dysfunctional and threatened the continued viability of the entire product line; (ii) as a result, the Company had materially overstated the continued commercial viability and profitability of the LOTUS Edge Aortic Valve System; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE BSX CLASS ACTION, CLICK HERE

If you suffered a loss in Boston Scientific you have until February 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery does not require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com